US equities
|
MU
$877.55
▲+2.46%
NVDA
$210.96
▼-0.59%
SPCX
$147.49
▲+1.89%
AAPL
$347.73
▼-0.14%
TSLA
$372.22
▼-0.63%
SNDK
$1,238.03
▼-1.82%
META
$642.62
▼-0.96%
AMD
$516.79
▲+1.74%
MU
$877.55
▲+2.46%
NVDA
$210.96
▼-0.59%
SPCX
$147.49
▲+1.89%
AAPL
$347.73
▼-0.14%
TSLA
$372.22
▼-0.63%
SNDK
$1,238.03
▼-1.82%
META
$642.62
▼-0.96%
AMD
$516.79
▲+1.74%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Neurodegenerative Disorder
Recent news which mentions Neurodegenerative Disorder
This Medical Stock Soared Over 80% In Pre-Market After Advancing Gene Therapy Program For ALS, Alzheimer's And Parkinson's Diseases
July 09, 2024
Tickers
ALS
NEWS
WENA
Tags
Pre/Market Outlook
Market News
Biotech
From
Benzinga
Novel Compound Begins Clinical Testing For Potential Treatment Of Multiple Sclerosis
April 17, 2023
Tickers
HUGE
Tags
General
Global
New Chemical Entity
From
Benzinga
Biogen's Antisense Candidate Flunks In Late-Stage Neurodegenerative Disorder Trial
October 18, 2021
Tickers
BIIB
IONS
Tags
Trading Ideas
Neurodegenerative Disorder
BIIB
From
Benzinga
FSD Pharma To Buy Canadian Psychedelic Pharmaceutical Firm
August 25, 2021
Tickers
HUGE
Tags
Movers
neuroscience
General
From
Benzinga
Exicure Stock Surges On Over $1B Option Licensing Pact With Ipsen For Rare Neurodegenerative Disorders
August 02, 2021
Tickers
IPSEF
IPSEY
XCUR
Tags
XCUR
Movers
IPSEY
From
Benzinga